Advertisement
U.S. markets open in 8 hours 39 minutes

Regen BioPharma, Inc. (RGBP)

Other OTC - Other OTC Delayed Price. Currency in USD
0.7200-0.0399 (-5.25%)
At close: 03:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.7599
Open0.7106
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.7105 - 0.7690
52 Week Range0.5222 - 2.6150
Volume8,224
Avg. Volume20,827
Market Cap2.7M
Beta (5Y Monthly)2.74
PE Ratio (TTM)N/A
EPS (TTM)-0.2600
Earnings DateApr 15, 2024 - Apr 19, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RGBP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • REGEN BIOPHARMA INC
    Analyst Report: Qiagen N.V.Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
    Rating
    Fair Value
    Economic Moat
    last monthMorningstar
View more
  • GlobeNewswire

    Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now

    MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani

  • CNW Group

    Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024

    Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on March 7, 2024 (https://emerginggrowth.com/conference/).

  • GlobeNewswire

    Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now

    MIAMI, Feb. 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 67th Emerging Growth Conference on February 7 & 8, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compa